MSP58 inhibitors are chemical compounds designed to specifically target and inhibit the function of MSP58, a protein also known as M-phase phosphoprotein 8. MSP58 is involved in several key cellular processes, including regulation of cell growth, proliferation, and chromatin organization. It acts as a multifunctional protein that interacts with other cellular proteins to modulate transcription and chromatin remodeling. Inhibitors of MSP58 are developed to disrupt its interactions with other molecules or to block its functional domains, thereby interfering with its role in cellular regulation. By targeting MSP58, researchers aim to understand its specific contributions to cell cycle regulation and chromatin dynamics.
Chemically, MSP58 inhibitors can vary in their structure and mode of action, including small molecules that bind to specific functional regions of the protein, such as its protein-protein interaction domains or DNA-binding motifs. These inhibitors might act by preventing MSP58 from associating with chromatin or blocking its interaction with other proteins involved in gene transcription. The design of MSP58 inhibitors typically focuses on achieving high specificity, ensuring that the compounds selectively target MSP58 without affecting related proteins. This specificity is important for dissecting the precise role of MSP58 in the complex networks of cellular regulation. Studying the effects of MSP58 inhibition can provide valuable insights into how this protein contributes to cellular homeostasis, chromatin structure, and the control of gene expression, as well as its involvement in broader biological processes such as cell division and growth. The use of MSP58 inhibitors helps to clarify the molecular mechanisms underlying its regulatory functions in cells.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
DNA methyltransferase inhibitor that can alter the epigenetic state and possibly affect MCRS1 activity. | ||||||
Nutlin-3 | 548472-68-0 | sc-45061 sc-45061A sc-45061B | 1 mg 5 mg 25 mg | $62.00 $225.00 $779.00 | 24 | |
p53 stabilizer that could indirectly inhibit MCRS1 by activating apoptosis. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
PI3K inhibitor that can interfere with signaling pathways involving MCRS1. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can affect cell cycle progression and potentially influence MCRS1 activity. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that can stabilize proteins that may regulate MCRS1. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
p38 MAPK inhibitor that can affect stress-response pathways involving MCRS1. | ||||||
ZM-447439 | 331771-20-1 | sc-200696 sc-200696A | 1 mg 10 mg | $153.00 $356.00 | 15 | |
Aurora kinase inhibitor that can inhibit cellular processes where MCRS1 is a participant. | ||||||
(±)-JQ1 | 1268524-69-1 | sc-472932 sc-472932A | 5 mg 25 mg | $231.00 $863.00 | 1 | |
BET bromodomain inhibitor that can influence the epigenetic state affecting MCRS1. | ||||||